Clinical Trials Browser

Interventional × HER2 Positive Breast Carcinoma × neratinib × Clear all

NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

Phase 2 Completed

25 enrolled 18 charts

HER2 Positive Breast Carcinoma